| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6192991 | Journal of Thoracic Oncology | 2015 | 7 Pages |
Abstract
These results confirm the activity of targeted therapy in patients with BRAF-mutant lung adenocarcinoma. Further trials are warranted to study combination therapies and drug resistance mechanisms.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Oliver MD, Julie PhD, Bastien MSc, Marie-Virginia MD, Benjamin MD, Egbert F MD, Juergen MD, Solange MD-PhD, Martin MD, Dieter MD, Youssouf MD, Martin MD, Alessandra MD, Benjamin MD, Mallorie MD, Sebastian MD, Georg MD, Sacha MD-PhD, Julien MD,